Dextran, Tetramethylrhodamine, 70,000 MW, Lysine Fixable and 1 more item

The University of Virginia awarded contract A207_PO-0480830 to Life Technologies Corporation on September 16, 2026, for the procurement of specialized research materials and biological reagents. The contract, valued at $952, encompasses the delivery of two distinct line items to Katie Knight at the University of Virginia. The first item consists of Dextran, Tetramethylrhodamine, 70,000 molecular weight, Lysine Fixable, priced at $391.02 per unit, with a quantity of one each. The second item is Human HGF (Hepatocyte Growth Factor) Recombinant Protein manufactured by PeproTech, priced at $561.65 per unit, also in a quantity of one each.

This procurement represents a purchase order arrangement typical of institutional research acquisition in Virginia's higher education sector. Life Technologies Corporation, as the prime contractor, fulfilled the order for laboratory-grade biological products required for research applications at the University of Virginia. The materials specified—fluorescently-labeled dextran and recombinant growth factor proteins—indicate the supplies are intended for life sciences research, including potential applications in cellular imaging and protein-based experimental protocols.